Sign in for the best experience.
As a CHEST member, you’re part of a strong network of clinicians representing every profession and experience level in chest medicine. With us, you can develop personal and professional connections, cultivate your leadership skills, advocate for policies that improve access to health, and advance your career.
JOIN TODAY ABOUT MEMBERSHIP »
Advertisement
Only five storytellers will be selected to share a piece of their personal story as a clinician in chest medicine at CHEST After Hours, Monday, October 20, in Chicago. Submissions are due Thursday, August 7.
LEARN MORE »
CHEST recently launched Bridging Specialties®: Timely Diagnosis for Nontuberculous Mycobacterial (NTM) Pulmonary Disease and Bronchiectasis as a way for primary care physicians and pulmonologists to collaborate and provide earlier and accurate diagnoses.
READ MORE »
CHEST recently cosigned a letter from the Action on Smoking & Health (ASH) to the Human Rights Council that focused on public health as it relates to global morbidity and mortality caused by tobacco.
In a new CHEST Physician® article, members of the Interventional Procedures Section discuss the importance of the VERITAS trial, which represents a turning point for interventional pulmonology, ushering in an era of high-quality comparative effectiveness trials poised to transform our approach to technology evaluation, implementation, and, ultimately, patient care.
New guidelines from the American Thoracic Society outline the screening and follow-up procedures for interstitial lung abnormalities (ILAs). In a CHEST Physician® article, members of the Interstitial Lung Disease Section highlight updates to the Fleischner Society ILA definition and recommendations outlined in the new guideline.
Biologics such as dupilumab, mepolizumab, benralizumab, and tezepelumab are an emerging option for select patients with asthma-COPD overlap (ACO), particularly those with T2-high inflammatory phenotypes. In a CHEST Physician® article, members of the Asthma and COPD Section highlight biomarker studies that have shown a reduction in exacerbations for patients with ACO.
Join the conversation on social media and connect with members of the CHEST community.
Enhance your clinical expertise, pass the boards, or study for the Longitudinal Knowledge Assessment.
Refine your skills in evaluating patients with suspected lung cancer and critical flexible bronchoscopy with a focus on endobronchial ultrasound and transbronchial needle aspiration, September 4 to 6.
Strengthen your clinical expertise and understanding of key critical care medicine concepts and strategies as an advanced practice provider (APP).
When you become an FCCP (Fellow of the American College of Chest Physicians), you play an active role in advancing the field of chest medicine while enjoying the prestige of being associated with a distinctive group of chest medicine professionals.
“I have found being an FCCP to be rewarding on a personal level, as well as a professional level. It has provided me with connections to colleagues nationally and internationally, and it has opened the door to leadership opportunities.”
– Thomas Van der Kloot, MD, FCCP
FIND OUT MORE